UPDATE: Protagonist Therapeutics (PTGX) Prices 7.5M Common Stock IPO at $12/Share, Flat with Expectations
Tweet Send to a Friend
(Updated - August 11, 2016 8:58 AM EDT)Protagonist Therapeutics, Inc. (Nasdaq: PTGX) announced the pricing of its initial public offering ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
